Bernd Schmidt
Chief Tech/Sci/R&D Officer presso SENSORION
Posizioni attive di Bernd Schmidt
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SENSORION | Chief Tech/Sci/R&D Officer | 11/12/2023 | - |
Storia della carriera di Bernd Schmidt
Precedenti posizioni note di Bernd Schmidt
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Quell Therapeutics Ltd.
 Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Quell Therapeutics Ltd. is a London-based biotechnology company, which develops immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases. It develops engineered T regulatory cell therapies for a variety of non-cancer targets. The company was founded on March 19, 2019 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - | - |
Formazione di Bernd Schmidt
| Friedrich-Alexander University of Erlangen-Nuremberg | Graduate Degree |
Statistiche
Distribuzione geografica
| Germania | 2 |
| Francia | 2 |
| Regno Unito | 2 |
Posizioni
| Graduate Degree | 1 |
| Corporate Officer/Principal | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SENSORION | Health Technology |
| Aziende private | 1 |
|---|---|
Quell Therapeutics Ltd.
Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Quell Therapeutics Ltd. is a London-based biotechnology company, which develops immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases. It develops engineered T regulatory cell therapies for a variety of non-cancer targets. The company was founded on March 19, 2019 and is headquartered in London, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Bernd Schmidt
- Esperienza
